1. The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors
    Guangjian Yang et al, 2022, Frontiers in Oncology CrossRef
  2. Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted
    Yajuan Gu et al, 2022, Pathology - Research and Practice CrossRef
  3. Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
    Oscar Arrieta et al, 2015, Journal of Thoracic Oncology CrossRef
  4. Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series
    Gilda da Cunha Santos et al, 2015, Cancer Cytopathology CrossRef
  5. Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status
    Wenzhao Zhong et al, 2015, Journal of Hematology & Oncology CrossRef
  6. Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk
    Yagmur Kan et al, 2023, Biochemistry CrossRef
  7. Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort
    Houda Kaanane et al, 2019, Gene CrossRef

  8. Great Efficacy of Afatinib in a Patient with Lung Adenocarcinoma Harboring EGFR L833V/H835L Mutations: A Case Report


    Xiang Long et al, 2020, OncoTargets and Therapy CrossRef
  9. Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant (L833V/H835L) lung adenocarcinoma patient: a case report
    Zhilin Luo et al, 2023, Anti-Cancer Drugs CrossRef
  10. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer
    Solène M. Evrard et al, 2019, The Journal of Molecular Diagnostics CrossRef
  11. High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis
    Rui Bi et al, 2020, Aging CrossRef